Biotrial
Biotrial is a France-founded, full-service contract research organization supporting pharmaceutical and biotechnology companies across drug development.
Last updated September 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Biotrial is a contract research organization (CRO) founded in France in 1989 by Jean-Marc Gandon, PharmD. The company describes itself as a mid-size, full-service CRO serving pharmaceutical and biotechnology companies. Its stated mission is to help sponsors develop innovative therapies and support the delivery of effective treatments to patients. The company offers services spanning early drug development through clinical research. Its capabilities include non-clinical pharmacology, clinical development, Phase I studies involving healthy volunteers and special populations, studies with patients, bioanalysis, biometrics, data management and biostatistics, and Core Lab services including ECG, CNS and imaging. Biotrial says its integrated model lets sponsors access non-clinical and clinical capabilities alongside supporting scientific and data services within one CRO. It offers tailored solutions and says it performs hundreds of studies each year. Biotrial began with a four-bed clinical pharmacology unit in France and subsequently expanded its services and operations. Its history page identifies Rennes as the location of its headquarters, established in a building constructed in 1997. The company describes itself as a global enterprise, with a workforce spanning multiple countries and services for sponsors worldwide. The supplied sources do not identify a parent company, owner, or public listing.
History
Biotrial was created in France in 1989 by Jean-Marc Gandon, PharmD. According to the company, Gandon conceived the CRO during his final year of pharmacy studies in the United States, with the aim of providing pharmaceutical and biotechnology companies with a trusted subcontractor offering high-quality, tailored support for developing and testing new therapies. The first operation was a clinical pharmacology unit with four beds. The company also established non-clinical services in 1989 to support sponsors during early development and accompany projects toward clinical development. In 1991, Biotrial created a Biometrics Unit to support its clinical activity. The company says this service later grew into an independent business unit supporting sponsors with the collection, management, analysis and reporting of data from non-clinical work through Phase IV clinical trials. In 1997, Biotrial constructed its first building, which the company identifies as its current headquarters in Rennes, France. Located near a hospital and a university, the building supported expansion of the Phase I unit and increased its capacity to 50 beds. The company’s history page records the opening of its first office outside France in 1999. The supplied excerpt does not provide the office location or further details about that opening. More broadly, Biotrial says that it expanded its operations and service range over time, evolving from a clinical pharmacology unit into a full-service CRO. Its current stated capabilities encompass non-clinical pharmacology, clinical development, bioanalysis, biometrics, data and laboratory services. The company describes its present reach as global, with a workforce spanning multiple countries and sponsors served worldwide. The available material does not specify its ownership, listing status, or the full chronology of its later expansions.
- 1999
First office outside France opened
- 1997
Rennes headquarters building constructed
- 1991
Biometrics Unit created
- 1989
Biotrial founded and first clinical pharmacology unit established
Products and positioning
A mid-size, full-service CRO offering tailored, integrated drug-development support to pharmaceutical and biotechnology sponsors, from non-clinical work through clinical studies and related laboratory and data services.
Non-clinical pharmacology
Non-clinical development services for pharmaceutical and biotechnology sponsors.
Clinical development
Clinical research including Phase I studies with healthy volunteers and special populations, as well as studies with patients.
Biometrics and bioanalysis
Supporting services for clinical and drug-development studies.
Core Lab
Specialized services that include ECG, CNS and imaging.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/biotrial · Editorial policy · How profiles are compiled